An Act To Conform Maine's Prescription Drug Privacy Laws with the United States Constitution
Sec. 1. 22 MRSA §1711-E, sub-§1-A, as enacted by PL 2007, c. 460, §1, is repealed.
Sec. 2. 22 MRSA §1711-E, sub-§1-B, as amended by PL 2011, c. 461, §1, is repealed.
Sec. 3. 22 MRSA §1711-E, sub-§2, as amended by PL 2007, c. 460, §1, is further amended to read:
Sec. 4. 22 MRSA §1711-E, sub-§2-A, as enacted by PL 2007, c. 460, §1, is repealed.
Sec. 5. 22 MRSA §1711-E, sub-§3, as amended by PL 2007, c. 460, §1, is further amended to read:
Sec. 6. 22 MRSA §1711-E, sub-§4, as enacted by PL 2007, c. 460, §1, is repealed.
Sec. 7. 22 MRSA §8704, sub-§4, as amended by PL 2007, c. 460, §2, is further amended to read:
Sec. 8. 22 MRSA §8704, sub-§7, as amended by PL 2007, c. 460, §3, is further amended to read:
As part of its annual report, the organization shall report on filings for confidentiality protection under section 1711-E, subsection 4, the disclosure of the names of prescribers who filed for confidentiality protection, funding through the assessment under section 1711-E, subsection 4, paragraph C and recommendations for legislation to improve operation of section 1711-E, subsection 4.
Sec. 9. 22 MRSA §8713, as enacted by PL 2007, c. 460, §4, is repealed.